In summary, physicians need to approach all manifestations of AVD, whether clinically symptomatic or silent, as one pathologic entity that intermittently affects different vascular territories. This approach will result in appropriate risk stratification and therapy, reductions in future events, and a better quality of life for our patients.
CITATION STYLE
Fuster, V., & Moreno, P. R. (2005, September). Atherothrombosis as a systematic, often silent, disease. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0310
Mendeley helps you to discover research relevant for your work.